Combined Effect of Sensory-motor Integration in Individuals With Postmenopausal Polyneuropathy (EMG)

February 27, 2026 updated by: Mohamed Abdel Moeim Abo EL Ros, New Ismailia National University

The Combination Effect of Sensory-motor Integration in Postmenopausal Polyneuropathy: A Randomized Controlled Trial

Detect the combined effect of sensory-motor integration in individuals with postmenopausal polyneuropathy

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

This reach aim to conduct to improve balance and reduce pain in patients with post-menopausal with peripheral neuropathy

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Egypt
  • Jordan
      • Amman, Jordan
        • Recruiting
        • Zaytona University in Jordon
        • Contact:
          • Mohamed M Abo-El-Ros, Ph.D
          • Phone Number: A 00960781524278
          • Email: 3767@zuj.edu.jo
        • Contact:
          • Kerolous I Kelini, Ph.D
          • Phone Number: S 00201229712126
          • Email: 3530@zuj.edu.jo
        • Principal Investigator:
          • Mohamed M Abo-El-Ros, Ph.D

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • polyneuropathy pos-tmaneuposal
  • Type II Diabetes Mellitus
  • Suffering from numbness in upper and lower limbs for more than 4 months

Exclusion Criteria:

  • hysterectomy
  • tumors
  • antidepressant dugs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A
has received Sensory Motor Integration was given in the form of tactile stimulation, thermal stimulation and proprioceptive stimulation as well as motor integration was given in the form of strengthening exercises and pelvic rocking training for 6 weeks
Other: sensory motor integration
pelvic rocking training and strengthening exercises
Other Names:
  • thermal, Tactile, and proprioceptive stimulation
Active Comparator: Broup B
will recieve conventional exercises in the form of Free exercises and gymnasium exercises of Upper limb and Lower limb along with 20 minutes walking
Other: traditional excercises
conventional
Other Names:
  • Free exercises and gymnasium exercises of Upper limb and Lower limb

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: 6 weeks
pain management will be evaluated by visual analogue scale with a minimum score of zero, and the maximum score is ten in addition, zero means a better score
6 weeks
balance assessment
Time Frame: 6 weeks
changes in balance parameters will be evaluated by the Biodex balance system that calculate the mediolateral stability index, anteroposterior stability index, and the overall. stability index.These indexes represent fluctuations around a zero point established before testing when the platform is stable. A high oSi score indicates poor balance, and the patient's maximum overall score would be 1.60.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

New Ismailia National University

Investigators

  • Study Director: Kerlos Kellini, Ph.D, Al Zaytona University in Jordon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2026

Primary Completion (Estimated)

May 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

January 31, 2026

First Submitted That Met QC Criteria

February 27, 2026

First Posted (Actual)

March 5, 2026

Study Record Updates

Last Update Posted (Actual)

March 5, 2026

Last Update Submitted That Met QC Criteria

February 27, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB # 5/1/2025-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No IPD sharing

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe